Top compounds associated with response to HIGD1A


Feature Type Standardized
Nominal ANOVA
mRNA alisertib CTRPv2 pan-cancer AAC -0.11 0.0007
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.0007
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 0.0008
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.14 0.002
mRNA semagacestat CTRPv2 pan-cancer AAC -0.12 0.002
mRNA Gefitinib FIMM pan-cancer AAC -0.5 0.003
Download CSV